nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorthalidone—SLC12A1—urine—urinary bladder cancer	0.0549	0.145	CbGeAlD
Chlorthalidone—CA5A—female reproductive system—urinary bladder cancer	0.0216	0.0572	CbGeAlD
Chlorthalidone—SLC12A1—prostate gland—urinary bladder cancer	0.0197	0.0521	CbGeAlD
Chlorthalidone—CA7—renal system—urinary bladder cancer	0.0179	0.0475	CbGeAlD
Chlorthalidone—SLC12A3—renal system—urinary bladder cancer	0.0176	0.0466	CbGeAlD
Chlorthalidone—CA5B—prostate gland—urinary bladder cancer	0.0153	0.0406	CbGeAlD
Chlorthalidone—SLC12A1—epithelium—urinary bladder cancer	0.0145	0.0383	CbGeAlD
Chlorthalidone—SLC12A3—female reproductive system—urinary bladder cancer	0.0141	0.0373	CbGeAlD
Chlorthalidone—SLC12A1—renal system—urinary bladder cancer	0.0134	0.0355	CbGeAlD
Chlorthalidone—SLC12A1—urethra—urinary bladder cancer	0.0132	0.0349	CbGeAlD
Chlorthalidone—CA9—female reproductive system—urinary bladder cancer	0.0126	0.0334	CbGeAlD
Chlorthalidone—CA12—renal system—urinary bladder cancer	0.0117	0.0309	CbGeAlD
Chlorthalidone—CA4—prostate gland—urinary bladder cancer	0.0106	0.028	CbGeAlD
Chlorthalidone—CA5B—urethra—urinary bladder cancer	0.0103	0.0272	CbGeAlD
Chlorthalidone—Clonazepam—NAT2—urinary bladder cancer	0.00987	1	CrCbGaD
Chlorthalidone—CA12—female reproductive system—urinary bladder cancer	0.00934	0.0247	CbGeAlD
Chlorthalidone—CA1—renal system—urinary bladder cancer	0.00924	0.0245	CbGeAlD
Chlorthalidone—CA4—seminal vesicle—urinary bladder cancer	0.00896	0.0237	CbGeAlD
Chlorthalidone—CA2—prostate gland—urinary bladder cancer	0.00878	0.0233	CbGeAlD
Chlorthalidone—CA5B—female reproductive system—urinary bladder cancer	0.00838	0.0222	CbGeAlD
Chlorthalidone—CA5B—vagina—urinary bladder cancer	0.00758	0.0201	CbGeAlD
Chlorthalidone—CA2—seminal vesicle—urinary bladder cancer	0.00743	0.0197	CbGeAlD
Chlorthalidone—CA1—female reproductive system—urinary bladder cancer	0.0074	0.0196	CbGeAlD
Chlorthalidone—CA4—renal system—urinary bladder cancer	0.00722	0.0191	CbGeAlD
Chlorthalidone—CA4—urethra—urinary bladder cancer	0.00709	0.0188	CbGeAlD
Chlorthalidone—CA2—epithelium—urinary bladder cancer	0.00645	0.0171	CbGeAlD
Chlorthalidone—CA2—smooth muscle tissue—urinary bladder cancer	0.00622	0.0165	CbGeAlD
Chlorthalidone—CA2—renal system—urinary bladder cancer	0.00599	0.0158	CbGeAlD
Chlorthalidone—CA4—female reproductive system—urinary bladder cancer	0.00578	0.0153	CbGeAlD
Chlorthalidone—Pulmonary oedema—Thiotepa—urinary bladder cancer	0.00548	0.0107	CcSEcCtD
Chlorthalidone—Appetite absent—Methotrexate—urinary bladder cancer	0.00533	0.0104	CcSEcCtD
Chlorthalidone—Vasculitis—Gemcitabine—urinary bladder cancer	0.00531	0.0104	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Cisplatin—urinary bladder cancer	0.00521	0.0102	CcSEcCtD
Chlorthalidone—Abdominal pain—Valrubicin—urinary bladder cancer	0.00501	0.00982	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Cisplatin—urinary bladder cancer	0.00492	0.00963	CcSEcCtD
Chlorthalidone—CA5B—lymph node—urinary bladder cancer	0.0049	0.013	CbGeAlD
Chlorthalidone—CA2—female reproductive system—urinary bladder cancer	0.00479	0.0127	CbGeAlD
Chlorthalidone—Leukopenia—Mitomycin—urinary bladder cancer	0.00479	0.00939	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Etoposide—urinary bladder cancer	0.00477	0.00934	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Gemcitabine—urinary bladder cancer	0.00461	0.00903	CcSEcCtD
Chlorthalidone—Asthenia—Valrubicin—urinary bladder cancer	0.00455	0.00891	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Etoposide—urinary bladder cancer	0.0045	0.00883	CcSEcCtD
Chlorthalidone—Diarrhoea—Valrubicin—urinary bladder cancer	0.00434	0.0085	CcSEcCtD
Chlorthalidone—CA2—vagina—urinary bladder cancer	0.00434	0.0115	CbGeAlD
Chlorthalidone—CA1—lymph node—urinary bladder cancer	0.00433	0.0115	CbGeAlD
Chlorthalidone—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00428	0.00838	CcSEcCtD
Chlorthalidone—Photosensitivity—Fluorouracil—urinary bladder cancer	0.00421	0.00825	CcSEcCtD
Chlorthalidone—Dizziness—Valrubicin—urinary bladder cancer	0.00419	0.00822	CcSEcCtD
Chlorthalidone—Anorexia—Mitomycin—urinary bladder cancer	0.00416	0.00816	CcSEcCtD
Chlorthalidone—Vomiting—Valrubicin—urinary bladder cancer	0.00403	0.0079	CcSEcCtD
Chlorthalidone—Rash—Valrubicin—urinary bladder cancer	0.004	0.00783	CcSEcCtD
Chlorthalidone—Dermatitis—Valrubicin—urinary bladder cancer	0.004	0.00783	CcSEcCtD
Chlorthalidone—Headache—Valrubicin—urinary bladder cancer	0.00397	0.00778	CcSEcCtD
Chlorthalidone—Hypomagnesaemia—Epirubicin—urinary bladder cancer	0.0039	0.00765	CcSEcCtD
Chlorthalidone—Decreased appetite—Mitomycin—urinary bladder cancer	0.0038	0.00744	CcSEcCtD
Chlorthalidone—Nausea—Valrubicin—urinary bladder cancer	0.00377	0.00738	CcSEcCtD
Chlorthalidone—Hypomagnesaemia—Doxorubicin—urinary bladder cancer	0.00361	0.00708	CcSEcCtD
Chlorthalidone—Hypercalcaemia—Epirubicin—urinary bladder cancer	0.00357	0.00699	CcSEcCtD
Chlorthalidone—Hyponatraemia—Cisplatin—urinary bladder cancer	0.00352	0.00689	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00349	0.00683	CcSEcCtD
Chlorthalidone—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00342	0.0067	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.00339	0.00663	CcSEcCtD
Chlorthalidone—CA4—lymph node—urinary bladder cancer	0.00338	0.00895	CbGeAlD
Chlorthalidone—Jaundice—Thiotepa—urinary bladder cancer	0.00336	0.00658	CcSEcCtD
Chlorthalidone—Hypercalcaemia—Doxorubicin—urinary bladder cancer	0.0033	0.00647	CcSEcCtD
Chlorthalidone—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00321	0.0063	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.0032	0.00627	CcSEcCtD
Chlorthalidone—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00319	0.00625	CcSEcCtD
Chlorthalidone—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00316	0.0062	CcSEcCtD
Chlorthalidone—Cramp muscle—Cisplatin—urinary bladder cancer	0.00316	0.00618	CcSEcCtD
Chlorthalidone—Asthenia—Mitomycin—urinary bladder cancer	0.00313	0.00614	CcSEcCtD
Chlorthalidone—Glycosuria—Epirubicin—urinary bladder cancer	0.00306	0.006	CcSEcCtD
Chlorthalidone—Diarrhoea—Mitomycin—urinary bladder cancer	0.00299	0.00586	CcSEcCtD
Chlorthalidone—Pancreatitis—Cisplatin—urinary bladder cancer	0.00297	0.00582	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00293	0.00574	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00292	0.00571	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.0029	0.00569	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.00289	0.00567	CcSEcCtD
Chlorthalidone—Cramp muscle—Etoposide—urinary bladder cancer	0.00289	0.00567	CcSEcCtD
Chlorthalidone—Dizziness—Mitomycin—urinary bladder cancer	0.00289	0.00566	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.00286	0.0056	CcSEcCtD
Chlorthalidone—Glycosuria—Doxorubicin—urinary bladder cancer	0.00283	0.00555	CcSEcCtD
Chlorthalidone—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00282	0.00553	CcSEcCtD
Chlorthalidone—CA2—lymph node—urinary bladder cancer	0.0028	0.00743	CbGeAlD
Chlorthalidone—Vomiting—Mitomycin—urinary bladder cancer	0.00278	0.00544	CcSEcCtD
Chlorthalidone—Arrhythmia—Thiotepa—urinary bladder cancer	0.00276	0.00541	CcSEcCtD
Chlorthalidone—Rash—Mitomycin—urinary bladder cancer	0.00275	0.0054	CcSEcCtD
Chlorthalidone—Dermatitis—Mitomycin—urinary bladder cancer	0.00275	0.00539	CcSEcCtD
Chlorthalidone—Headache—Mitomycin—urinary bladder cancer	0.00274	0.00536	CcSEcCtD
Chlorthalidone—Vasculitis—Methotrexate—urinary bladder cancer	0.00271	0.00532	CcSEcCtD
Chlorthalidone—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.0027	0.0053	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.0027	0.00529	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.00267	0.00524	CcSEcCtD
Chlorthalidone—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00266	0.00521	CcSEcCtD
Chlorthalidone—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00261	0.00512	CcSEcCtD
Chlorthalidone—Nausea—Mitomycin—urinary bladder cancer	0.0026	0.00508	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.00253	0.00495	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00249	0.00487	CcSEcCtD
Chlorthalidone—Agitation—Thiotepa—urinary bladder cancer	0.00247	0.00485	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.00247	0.00485	CcSEcCtD
Chlorthalidone—Jaundice—Etoposide—urinary bladder cancer	0.00241	0.00473	CcSEcCtD
Chlorthalidone—Leukopenia—Thiotepa—urinary bladder cancer	0.00241	0.00472	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.00236	0.00462	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.00234	0.00458	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00233	0.00456	CcSEcCtD
Chlorthalidone—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00232	0.00455	CcSEcCtD
Chlorthalidone—Agranulocytosis—Etoposide—urinary bladder cancer	0.00231	0.00452	CcSEcCtD
Chlorthalidone—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00229	0.00448	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.00221	0.00433	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.00221	0.00432	CcSEcCtD
Chlorthalidone—Photosensitivity—Methotrexate—urinary bladder cancer	0.00219	0.00429	CcSEcCtD
Chlorthalidone—Arrhythmia—Cisplatin—urinary bladder cancer	0.00217	0.00424	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00215	0.00422	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00215	0.00421	CcSEcCtD
Chlorthalidone—Anorexia—Thiotepa—urinary bladder cancer	0.00209	0.0041	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.00207	0.00405	CcSEcCtD
Chlorthalidone—Photosensitivity—Epirubicin—urinary bladder cancer	0.00205	0.00402	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.00204	0.004	CcSEcCtD
Chlorthalidone—Muscle spasms—Cisplatin—urinary bladder cancer	0.00203	0.00398	CcSEcCtD
Chlorthalidone—Leukopenia—Gemcitabine—urinary bladder cancer	0.00203	0.00397	CcSEcCtD
Chlorthalidone—Vascular purpura—Epirubicin—urinary bladder cancer	0.00201	0.00394	CcSEcCtD
Chlorthalidone—Leukopenia—Fluorouracil—urinary bladder cancer	0.00199	0.0039	CcSEcCtD
Chlorthalidone—Paraesthesia—Thiotepa—urinary bladder cancer	0.00197	0.00387	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.00191	0.00375	CcSEcCtD
Chlorthalidone—Decreased appetite—Thiotepa—urinary bladder cancer	0.00191	0.00374	CcSEcCtD
Chlorthalidone—Photosensitivity—Doxorubicin—urinary bladder cancer	0.0019	0.00372	CcSEcCtD
Chlorthalidone—Leukopenia—Cisplatin—urinary bladder cancer	0.00189	0.0037	CcSEcCtD
Chlorthalidone—Constipation—Thiotepa—urinary bladder cancer	0.00188	0.00368	CcSEcCtD
Chlorthalidone—Purpura—Epirubicin—urinary bladder cancer	0.00187	0.00366	CcSEcCtD
Chlorthalidone—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00186	0.00365	CcSEcCtD
Chlorthalidone—Muscle spasms—Etoposide—urinary bladder cancer	0.00186	0.00364	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00181	0.00355	CcSEcCtD
Chlorthalidone—Hyponatraemia—Epirubicin—urinary bladder cancer	0.00181	0.00354	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00178	0.00349	CcSEcCtD
Chlorthalidone—Anorexia—Gemcitabine—urinary bladder cancer	0.00176	0.00345	CcSEcCtD
Chlorthalidone—Urticaria—Thiotepa—urinary bladder cancer	0.00175	0.00342	CcSEcCtD
Chlorthalidone—Vertigo—Etoposide—urinary bladder cancer	0.00174	0.0034	CcSEcCtD
Chlorthalidone—Abdominal pain—Thiotepa—urinary bladder cancer	0.00174	0.0034	CcSEcCtD
Chlorthalidone—CA9—Cellular response to hypoxia—CREBBP—urinary bladder cancer	0.00174	0.017	CbGpPWpGaD
Chlorthalidone—Anorexia—Fluorouracil—urinary bladder cancer	0.00173	0.00339	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00173	0.00339	CcSEcCtD
Chlorthalidone—Leukopenia—Etoposide—urinary bladder cancer	0.00173	0.00339	CcSEcCtD
Chlorthalidone—Purpura—Doxorubicin—urinary bladder cancer	0.00173	0.00339	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.00171	0.0167	CbGpPWpGaD
Chlorthalidone—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00169	0.0033	CcSEcCtD
Chlorthalidone—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00167	0.00328	CcSEcCtD
Chlorthalidone—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00166	0.00325	CcSEcCtD
Chlorthalidone—Eosinophilia—Methotrexate—urinary bladder cancer	0.00165	0.00322	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00164	0.00322	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00164	0.00322	CcSEcCtD
Chlorthalidone—Anorexia—Cisplatin—urinary bladder cancer	0.00164	0.00322	CcSEcCtD
Chlorthalidone—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00164	0.00321	CcSEcCtD
Chlorthalidone—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00163	0.0032	CcSEcCtD
Chlorthalidone—Pancreatitis—Methotrexate—urinary bladder cancer	0.00163	0.00319	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00162	0.00318	CcSEcCtD
Chlorthalidone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00162	0.00317	CcSEcCtD
Chlorthalidone—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00161	0.00315	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00159	0.00312	CcSEcCtD
Chlorthalidone—Constipation—Gemcitabine—urinary bladder cancer	0.00158	0.0031	CcSEcCtD
Chlorthalidone—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00158	0.00309	CcSEcCtD
Chlorthalidone—Asthenia—Thiotepa—urinary bladder cancer	0.00158	0.00309	CcSEcCtD
Chlorthalidone—Paraesthesia—Cisplatin—urinary bladder cancer	0.00155	0.00303	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00155	0.00303	CcSEcCtD
Chlorthalidone—Eosinophilia—Epirubicin—urinary bladder cancer	0.00154	0.00302	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00153	0.003	CcSEcCtD
Chlorthalidone—Pancreatitis—Epirubicin—urinary bladder cancer	0.00153	0.00299	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00152	0.00298	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00152	0.00298	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00152	0.00297	CcSEcCtD
Chlorthalidone—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00152	0.00297	CcSEcCtD
Chlorthalidone—Anorexia—Etoposide—urinary bladder cancer	0.0015	0.00295	CcSEcCtD
Chlorthalidone—Diarrhoea—Thiotepa—urinary bladder cancer	0.0015	0.00295	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.0015	0.00294	CcSEcCtD
Chlorthalidone—Decreased appetite—Cisplatin—urinary bladder cancer	0.0015	0.00293	CcSEcCtD
Chlorthalidone—Dizziness—Thiotepa—urinary bladder cancer	0.00145	0.00285	CcSEcCtD
Chlorthalidone—Urticaria—Fluorouracil—urinary bladder cancer	0.00144	0.00283	CcSEcCtD
Chlorthalidone—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00143	0.00279	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00142	0.00278	CcSEcCtD
Chlorthalidone—Paraesthesia—Etoposide—urinary bladder cancer	0.00142	0.00278	CcSEcCtD
Chlorthalidone—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00141	0.00276	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.0014	0.00275	CcSEcCtD
Chlorthalidone—Vomiting—Thiotepa—urinary bladder cancer	0.0014	0.00274	CcSEcCtD
Chlorthalidone—Rash—Thiotepa—urinary bladder cancer	0.00139	0.00271	CcSEcCtD
Chlorthalidone—Dermatitis—Thiotepa—urinary bladder cancer	0.00138	0.00271	CcSEcCtD
Chlorthalidone—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00138	0.00271	CcSEcCtD
Chlorthalidone—Headache—Thiotepa—urinary bladder cancer	0.00138	0.0027	CcSEcCtD
Chlorthalidone—Decreased appetite—Etoposide—urinary bladder cancer	0.00137	0.00269	CcSEcCtD
Chlorthalidone—Jaundice—Epirubicin—urinary bladder cancer	0.00135	0.00265	CcSEcCtD
Chlorthalidone—Constipation—Etoposide—urinary bladder cancer	0.00135	0.00264	CcSEcCtD
Chlorthalidone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00134	0.00262	CcSEcCtD
Chlorthalidone—Asthenia—Gemcitabine—urinary bladder cancer	0.00133	0.0026	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00131	0.00257	CcSEcCtD
Chlorthalidone—Nausea—Thiotepa—urinary bladder cancer	0.00131	0.00256	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.0013	0.00254	CcSEcCtD
Chlorthalidone—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00129	0.00254	CcSEcCtD
Chlorthalidone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00127	0.00249	CcSEcCtD
Chlorthalidone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00126	0.00248	CcSEcCtD
Chlorthalidone—Urticaria—Etoposide—urinary bladder cancer	0.00125	0.00246	CcSEcCtD
Chlorthalidone—Jaundice—Doxorubicin—urinary bladder cancer	0.00125	0.00245	CcSEcCtD
Chlorthalidone—Abdominal pain—Etoposide—urinary bladder cancer	0.00125	0.00244	CcSEcCtD
Chlorthalidone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00124	0.00244	CcSEcCtD
Chlorthalidone—Asthenia—Cisplatin—urinary bladder cancer	0.00124	0.00242	CcSEcCtD
Chlorthalidone—Dizziness—Fluorouracil—urinary bladder cancer	0.0012	0.00235	CcSEcCtD
Chlorthalidone—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.0012	0.00235	CcSEcCtD
Chlorthalidone—CA9—Cellular response to hypoxia—EP300—urinary bladder cancer	0.00118	0.0116	CbGpPWpGaD
Chlorthalidone—Diarrhoea—Cisplatin—urinary bladder cancer	0.00118	0.00231	CcSEcCtD
Chlorthalidone—Vomiting—Gemcitabine—urinary bladder cancer	0.00118	0.0023	CcSEcCtD
Chlorthalidone—Rash—Gemcitabine—urinary bladder cancer	0.00117	0.00228	CcSEcCtD
Chlorthalidone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00116	0.00228	CcSEcCtD
Chlorthalidone—Hypersensitivity—Etoposide—urinary bladder cancer	0.00116	0.00228	CcSEcCtD
Chlorthalidone—Headache—Gemcitabine—urinary bladder cancer	0.00116	0.00227	CcSEcCtD
Chlorthalidone—Vomiting—Fluorouracil—urinary bladder cancer	0.00116	0.00226	CcSEcCtD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00115	0.0113	CbGpPWpGaD
Chlorthalidone—Rash—Fluorouracil—urinary bladder cancer	0.00115	0.00224	CcSEcCtD
Chlorthalidone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00114	0.00224	CcSEcCtD
Chlorthalidone—Headache—Fluorouracil—urinary bladder cancer	0.00114	0.00223	CcSEcCtD
Chlorthalidone—Asthenia—Etoposide—urinary bladder cancer	0.00113	0.00222	CcSEcCtD
Chlorthalidone—Arrhythmia—Epirubicin—urinary bladder cancer	0.00111	0.00218	CcSEcCtD
Chlorthalidone—Nausea—Gemcitabine—urinary bladder cancer	0.0011	0.00215	CcSEcCtD
Chlorthalidone—Vomiting—Cisplatin—urinary bladder cancer	0.0011	0.00215	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.00109	0.0107	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.00109	0.0107	CbGpPWpGaD
Chlorthalidone—Rash—Cisplatin—urinary bladder cancer	0.00109	0.00213	CcSEcCtD
Chlorthalidone—Dermatitis—Cisplatin—urinary bladder cancer	0.00109	0.00213	CcSEcCtD
Chlorthalidone—Diarrhoea—Etoposide—urinary bladder cancer	0.00108	0.00212	CcSEcCtD
Chlorthalidone—Nausea—Fluorouracil—urinary bladder cancer	0.00108	0.00211	CcSEcCtD
Chlorthalidone—Dizziness—Etoposide—urinary bladder cancer	0.00104	0.00204	CcSEcCtD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00104	0.0102	CbGpPWpGaD
Chlorthalidone—Muscle spasms—Epirubicin—urinary bladder cancer	0.00104	0.00204	CcSEcCtD
Chlorthalidone—Vertigo—Methotrexate—urinary bladder cancer	0.00104	0.00204	CcSEcCtD
Chlorthalidone—Leukopenia—Methotrexate—urinary bladder cancer	0.00104	0.00203	CcSEcCtD
Chlorthalidone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00103	0.00202	CcSEcCtD
Chlorthalidone—Nausea—Cisplatin—urinary bladder cancer	0.00102	0.002	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.00102	0.01	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—VHL—urinary bladder cancer	0.00102	0.01	CbGpPWpGaD
Chlorthalidone—Vomiting—Etoposide—urinary bladder cancer	0.001	0.00197	CcSEcCtD
Chlorthalidone—Agitation—Epirubicin—urinary bladder cancer	0.000996	0.00195	CcSEcCtD
Chlorthalidone—Rash—Etoposide—urinary bladder cancer	0.000995	0.00195	CcSEcCtD
Chlorthalidone—Dermatitis—Etoposide—urinary bladder cancer	0.000994	0.00195	CcSEcCtD
Chlorthalidone—Headache—Etoposide—urinary bladder cancer	0.000989	0.00194	CcSEcCtD
Chlorthalidone—Vertigo—Epirubicin—urinary bladder cancer	0.000974	0.00191	CcSEcCtD
Chlorthalidone—Leukopenia—Epirubicin—urinary bladder cancer	0.00097	0.0019	CcSEcCtD
Chlorthalidone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000964	0.00189	CcSEcCtD
Chlorthalidone—Nausea—Etoposide—urinary bladder cancer	0.000937	0.00184	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000926	0.00181	CcSEcCtD
Chlorthalidone—Agitation—Doxorubicin—urinary bladder cancer	0.000922	0.00181	CcSEcCtD
Chlorthalidone—Vertigo—Doxorubicin—urinary bladder cancer	0.000901	0.00177	CcSEcCtD
Chlorthalidone—Anorexia—Methotrexate—urinary bladder cancer	0.000901	0.00177	CcSEcCtD
Chlorthalidone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000898	0.00176	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000866	0.0017	CcSEcCtD
Chlorthalidone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000849	0.00166	CcSEcCtD
Chlorthalidone—Anorexia—Epirubicin—urinary bladder cancer	0.000843	0.00165	CcSEcCtD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000831	0.00815	CbGpPWpGaD
Chlorthalidone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000822	0.00161	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000802	0.00157	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000799	0.00783	CbGpPWpGaD
Chlorthalidone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000794	0.00156	CcSEcCtD
Chlorthalidone—Anorexia—Doxorubicin—urinary bladder cancer	0.00078	0.00153	CcSEcCtD
Chlorthalidone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000769	0.00151	CcSEcCtD
Chlorthalidone—Constipation—Epirubicin—urinary bladder cancer	0.000757	0.00148	CcSEcCtD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000754	0.0074	CbGpPWpGaD
Chlorthalidone—Urticaria—Methotrexate—urinary bladder cancer	0.000751	0.00147	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000749	0.00735	CbGpPWpGaD
Chlorthalidone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000747	0.00146	CcSEcCtD
Chlorthalidone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000735	0.00144	CcSEcCtD
Chlorthalidone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000712	0.00139	CcSEcCtD
Chlorthalidone—Urticaria—Epirubicin—urinary bladder cancer	0.000703	0.00138	CcSEcCtD
Chlorthalidone—Constipation—Doxorubicin—urinary bladder cancer	0.0007	0.00137	CcSEcCtD
Chlorthalidone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000699	0.00137	CcSEcCtD
Chlorthalidone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000697	0.00136	CcSEcCtD
Chlorthalidone—Asthenia—Methotrexate—urinary bladder cancer	0.000678	0.00133	CcSEcCtD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000677	0.00664	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000656	0.00644	CbGpPWpGaD
Chlorthalidone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000652	0.00128	CcSEcCtD
Chlorthalidone—Urticaria—Doxorubicin—urinary bladder cancer	0.00065	0.00127	CcSEcCtD
Chlorthalidone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000647	0.00127	CcSEcCtD
Chlorthalidone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000647	0.00127	CcSEcCtD
Chlorthalidone—CA5A—Metabolism—GSTZ1—urinary bladder cancer	0.000645	0.00633	CbGpPWpGaD
Chlorthalidone—Asthenia—Epirubicin—urinary bladder cancer	0.000635	0.00124	CcSEcCtD
Chlorthalidone—Dizziness—Methotrexate—urinary bladder cancer	0.000625	0.00122	CcSEcCtD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000615	0.00603	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.000613	0.00602	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—GSTO2—urinary bladder cancer	0.000611	0.006	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—NAT1—urinary bladder cancer	0.000611	0.006	CbGpPWpGaD
Chlorthalidone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000605	0.00119	CcSEcCtD
Chlorthalidone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000603	0.00118	CcSEcCtD
Chlorthalidone—CA7—Metabolism—GSTZ1—urinary bladder cancer	0.000602	0.00591	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—GSTZ1—urinary bladder cancer	0.000602	0.00591	CbGpPWpGaD
Chlorthalidone—Vomiting—Methotrexate—urinary bladder cancer	0.000601	0.00118	CcSEcCtD
Chlorthalidone—Rash—Methotrexate—urinary bladder cancer	0.000596	0.00117	CcSEcCtD
Chlorthalidone—Dermatitis—Methotrexate—urinary bladder cancer	0.000596	0.00117	CcSEcCtD
Chlorthalidone—Headache—Methotrexate—urinary bladder cancer	0.000592	0.00116	CcSEcCtD
Chlorthalidone—Asthenia—Doxorubicin—urinary bladder cancer	0.000587	0.00115	CcSEcCtD
Chlorthalidone—CA9—Cellular responses to stress—RBX1—urinary bladder cancer	0.000587	0.00576	CbGpPWpGaD
Chlorthalidone—Dizziness—Epirubicin—urinary bladder cancer	0.000585	0.00115	CcSEcCtD
Chlorthalidone—CA5B—Metabolism—GSTO2—urinary bladder cancer	0.000571	0.0056	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—GSTO2—urinary bladder cancer	0.000571	0.0056	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—NAT1—urinary bladder cancer	0.000571	0.0056	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—NAT1—urinary bladder cancer	0.000571	0.0056	CbGpPWpGaD
Chlorthalidone—Vomiting—Epirubicin—urinary bladder cancer	0.000563	0.0011	CcSEcCtD
Chlorthalidone—Nausea—Methotrexate—urinary bladder cancer	0.000562	0.0011	CcSEcCtD
Chlorthalidone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00056	0.0011	CcSEcCtD
Chlorthalidone—CA5A—Metabolism—UGT2B7—urinary bladder cancer	0.000559	0.00548	CbGpPWpGaD
Chlorthalidone—Rash—Epirubicin—urinary bladder cancer	0.000558	0.00109	CcSEcCtD
Chlorthalidone—CA12—Metabolism—GSTZ1—urinary bladder cancer	0.000558	0.00547	CbGpPWpGaD
Chlorthalidone—Dermatitis—Epirubicin—urinary bladder cancer	0.000557	0.00109	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000554	0.00544	CbGpPWpGaD
Chlorthalidone—Headache—Epirubicin—urinary bladder cancer	0.000554	0.00109	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000544	0.00534	CbGpPWpGaD
Chlorthalidone—Dizziness—Doxorubicin—urinary bladder cancer	0.000541	0.00106	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000536	0.00526	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—GSTO2—urinary bladder cancer	0.000529	0.00519	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—NAT1—urinary bladder cancer	0.000529	0.00519	CbGpPWpGaD
Chlorthalidone—Nausea—Epirubicin—urinary bladder cancer	0.000526	0.00103	CcSEcCtD
Chlorthalidone—CA5B—Metabolism—UGT2B7—urinary bladder cancer	0.000522	0.00512	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—UGT2B7—urinary bladder cancer	0.000522	0.00512	CbGpPWpGaD
Chlorthalidone—Vomiting—Doxorubicin—urinary bladder cancer	0.00052	0.00102	CcSEcCtD
Chlorthalidone—Rash—Doxorubicin—urinary bladder cancer	0.000516	0.00101	CcSEcCtD
Chlorthalidone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000516	0.00101	CcSEcCtD
Chlorthalidone—Headache—Doxorubicin—urinary bladder cancer	0.000513	0.001	CcSEcCtD
Chlorthalidone—CA1—C-MYB transcription factor network—EP300—urinary bladder cancer	0.00051	0.005	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—CYP4B1—urinary bladder cancer	0.000503	0.00494	CbGpPWpGaD
Chlorthalidone—Nausea—Doxorubicin—urinary bladder cancer	0.000486	0.000953	CcSEcCtD
Chlorthalidone—CA12—Metabolism—UGT2B7—urinary bladder cancer	0.000484	0.00474	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—SLC19A1—urinary bladder cancer	0.000475	0.00466	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—CYP4B1—urinary bladder cancer	0.00047	0.00461	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—CYP4B1—urinary bladder cancer	0.00047	0.00461	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PRSS3—urinary bladder cancer	0.000463	0.00454	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000457	0.00449	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—GSTZ1—urinary bladder cancer	0.000445	0.00436	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—MYC—urinary bladder cancer	0.000445	0.00436	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—SLC19A1—urinary bladder cancer	0.000444	0.00435	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—SLC19A1—urinary bladder cancer	0.000444	0.00435	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—CYP4B1—urinary bladder cancer	0.000435	0.00427	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PRSS3—urinary bladder cancer	0.000433	0.00424	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PRSS3—urinary bladder cancer	0.000433	0.00424	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—GSTZ1—urinary bladder cancer	0.000426	0.00418	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—GSTO2—urinary bladder cancer	0.000422	0.00414	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—NAT1—urinary bladder cancer	0.000422	0.00414	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—GSTP1—urinary bladder cancer	0.000416	0.00409	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000415	0.00408	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—SLC19A1—urinary bladder cancer	0.000411	0.00403	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000411	0.00403	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—GSTZ1—urinary bladder cancer	0.000409	0.00401	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—GSTO2—urinary bladder cancer	0.000404	0.00397	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—NAT1—urinary bladder cancer	0.000404	0.00397	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PRSS3—urinary bladder cancer	0.000401	0.00393	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—CCNE1—urinary bladder cancer	0.000394	0.00387	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—GSTO2—urinary bladder cancer	0.000388	0.0038	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—NAT1—urinary bladder cancer	0.000388	0.0038	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—UGT2B7—urinary bladder cancer	0.000386	0.00378	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—SOD2—urinary bladder cancer	0.000384	0.00377	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—TYMP—urinary bladder cancer	0.00037	0.00363	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.00037	0.00363	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—GPX1—urinary bladder cancer	0.000366	0.0036	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—GSTZ1—urinary bladder cancer	0.000359	0.00353	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—UGT2B7—urinary bladder cancer	0.000354	0.00348	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000349	0.00343	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—CYP4B1—urinary bladder cancer	0.000347	0.00341	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—TYMP—urinary bladder cancer	0.000346	0.00339	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—TYMP—urinary bladder cancer	0.000346	0.00339	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—GSTO2—urinary bladder cancer	0.000341	0.00334	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—NAT1—urinary bladder cancer	0.000341	0.00334	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—NAT2—urinary bladder cancer	0.000335	0.00329	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000333	0.00327	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000328	0.00322	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—TYMP—urinary bladder cancer	0.00032	0.00314	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PRSS3—urinary bladder cancer	0.00032	0.00313	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000319	0.00313	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000314	0.00308	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—NAT2—urinary bladder cancer	0.000313	0.00307	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—NAT2—urinary bladder cancer	0.000313	0.00307	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.000312	0.00306	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000306	0.00301	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.000303	0.00297	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000302	0.00296	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000301	0.00296	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PRSS3—urinary bladder cancer	0.000294	0.00288	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—NAT2—urinary bladder cancer	0.00029	0.00284	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—RRM2—urinary bladder cancer	0.000289	0.00284	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000281	0.00275	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—RRM2—urinary bladder cancer	0.00027	0.00265	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—RRM2—urinary bladder cancer	0.00027	0.00265	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—HPGDS—urinary bladder cancer	0.000268	0.00263	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—ENO2—urinary bladder cancer	0.000268	0.00263	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000265	0.0026	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000263	0.00258	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000262	0.00257	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—GSTT1—urinary bladder cancer	0.00026	0.00255	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PRSS3—urinary bladder cancer	0.000258	0.00253	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—TYMP—urinary bladder cancer	0.000255	0.00251	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—RRM2—urinary bladder cancer	0.00025	0.00245	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—ENO2—urinary bladder cancer	0.00025	0.00245	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.00025	0.00245	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—ENO2—urinary bladder cancer	0.00025	0.00245	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—HPGDS—urinary bladder cancer	0.00025	0.00245	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—TYMP—urinary bladder cancer	0.000245	0.0024	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—GSTT1—urinary bladder cancer	0.000242	0.00238	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.000242	0.00238	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—TYMP—urinary bladder cancer	0.000235	0.0023	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—HPGDS—urinary bladder cancer	0.000232	0.00227	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—ENO2—urinary bladder cancer	0.000232	0.00227	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—NAT2—urinary bladder cancer	0.000231	0.00227	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000231	0.00226	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000225	0.0022	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—NAT2—urinary bladder cancer	0.000221	0.00217	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—NQO1—urinary bladder cancer	0.000216	0.00212	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000214	0.0021	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—NAT2—urinary bladder cancer	0.000212	0.00208	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000209	0.00205	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—TYMP—urinary bladder cancer	0.000206	0.00202	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000202	0.00198	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—NQO1—urinary bladder cancer	0.000202	0.00198	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—RRM2—urinary bladder cancer	0.000199	0.00196	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000194	0.00191	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—RRM2—urinary bladder cancer	0.000191	0.00188	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000189	0.00185	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—NQO1—urinary bladder cancer	0.000187	0.00183	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—NAT2—urinary bladder cancer	0.000187	0.00183	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—ENO2—urinary bladder cancer	0.000185	0.00181	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000185	0.00181	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—RRM2—urinary bladder cancer	0.000183	0.0018	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—GSTP1—urinary bladder cancer	0.00018	0.00177	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000179	0.00176	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000179	0.00176	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000177	0.00174	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—ENO2—urinary bladder cancer	0.000177	0.00174	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000172	0.00168	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—HPGDS—urinary bladder cancer	0.00017	0.00167	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—ENO2—urinary bladder cancer	0.00017	0.00167	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—GSTP1—urinary bladder cancer	0.000168	0.00165	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000168	0.00165	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—TYMS—urinary bladder cancer	0.000167	0.00164	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—NCOR1—urinary bladder cancer	0.000165	0.00162	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—GSTM1—urinary bladder cancer	0.000165	0.00162	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—GSTT1—urinary bladder cancer	0.000165	0.00162	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—RRM2—urinary bladder cancer	0.000161	0.00158	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—GPX1—urinary bladder cancer	0.000158	0.00155	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—TYMS—urinary bladder cancer	0.000156	0.00153	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—TYMS—urinary bladder cancer	0.000156	0.00153	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—GSTP1—urinary bladder cancer	0.000156	0.00153	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—ERCC2—urinary bladder cancer	0.000156	0.00153	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000154	0.00152	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000154	0.00152	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—GSTM1—urinary bladder cancer	0.000154	0.00152	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—NCOR1—urinary bladder cancer	0.000154	0.00152	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000149	0.00146	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—ENO2—urinary bladder cancer	0.000149	0.00146	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—NQO1—urinary bladder cancer	0.000149	0.00146	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—GPX1—urinary bladder cancer	0.000148	0.00145	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—GPX1—urinary bladder cancer	0.000148	0.00145	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—MTHFR—urinary bladder cancer	0.000146	0.00143	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—ERCC2—urinary bladder cancer	0.000145	0.00142	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000145	0.00142	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—TYMS—urinary bladder cancer	0.000145	0.00142	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000145	0.00142	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—GSTM1—urinary bladder cancer	0.000143	0.0014	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—NCOR1—urinary bladder cancer	0.000143	0.0014	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—NQO1—urinary bladder cancer	0.000143	0.0014	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—GPX1—urinary bladder cancer	0.000137	0.00134	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—NQO1—urinary bladder cancer	0.000137	0.00134	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—MTHFR—urinary bladder cancer	0.000136	0.00134	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000136	0.00134	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—ERCC2—urinary bladder cancer	0.000135	0.00132	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000128	0.00126	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—MTHFR—urinary bladder cancer	0.000126	0.00124	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000124	0.00122	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—NQO1—urinary bladder cancer	0.00012	0.00118	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000119	0.00117	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PPARG—urinary bladder cancer	0.000119	0.00116	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—TYMS—urinary bladder cancer	0.000115	0.00113	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000114	0.00112	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000114	0.00112	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000114	0.00112	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—CREBBP—urinary bladder cancer	0.000114	0.00112	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PPARG—urinary bladder cancer	0.000111	0.00109	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000111	0.00109	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—TYMS—urinary bladder cancer	0.000111	0.00109	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000109	0.00107	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000109	0.00107	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—GPX1—urinary bladder cancer	0.000109	0.00107	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000107	0.00105	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000106	0.00104	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—CREBBP—urinary bladder cancer	0.000106	0.00104	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—TYMS—urinary bladder cancer	0.000106	0.00104	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000105	0.00103	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000105	0.00103	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—GPX1—urinary bladder cancer	0.000105	0.00103	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000103	0.00101	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PPARG—urinary bladder cancer	0.000103	0.00101	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000101	0.000989	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—GPX1—urinary bladder cancer	0.0001	0.000985	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—GSTP1—urinary bladder cancer	0.0001	0.000984	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—ERCC2—urinary bladder cancer	9.86e-05	0.000967	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—CREBBP—urinary bladder cancer	9.85e-05	0.000966	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—MTHFR—urinary bladder cancer	9.67e-05	0.000948	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—TYMS—urinary bladder cancer	9.33e-05	0.000915	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PTGS2—urinary bladder cancer	9.33e-05	0.000915	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—MTHFR—urinary bladder cancer	9.27e-05	0.000909	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—NCOR1—urinary bladder cancer	9.22e-05	0.000904	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—GSTM1—urinary bladder cancer	9.22e-05	0.000904	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—GPX1—urinary bladder cancer	8.83e-05	0.000866	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PTGS2—urinary bladder cancer	8.71e-05	0.000854	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PTGS2—urinary bladder cancer	8.71e-05	0.000854	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—ERCC2—urinary bladder cancer	8.67e-05	0.00085	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PPARG—urinary bladder cancer	8.18e-05	0.000802	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—MTHFR—urinary bladder cancer	8.15e-05	0.000799	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PTEN—urinary bladder cancer	8.13e-05	0.000798	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PTGS2—urinary bladder cancer	8.07e-05	0.000791	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—CREBBP—urinary bladder cancer	7.86e-05	0.000771	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PPARG—urinary bladder cancer	7.84e-05	0.000769	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—EP300—urinary bladder cancer	7.76e-05	0.000761	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PTEN—urinary bladder cancer	7.59e-05	0.000745	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PTEN—urinary bladder cancer	7.59e-05	0.000745	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—CREBBP—urinary bladder cancer	7.53e-05	0.000739	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PPARG—urinary bladder cancer	7.52e-05	0.000737	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—EP300—urinary bladder cancer	7.24e-05	0.00071	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—EP300—urinary bladder cancer	7.24e-05	0.00071	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—CREBBP—urinary bladder cancer	7.22e-05	0.000708	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PTEN—urinary bladder cancer	7.03e-05	0.00069	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—EP300—urinary bladder cancer	6.71e-05	0.000658	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PPARG—urinary bladder cancer	6.61e-05	0.000648	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PTGS2—urinary bladder cancer	6.43e-05	0.000631	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—CREBBP—urinary bladder cancer	6.35e-05	0.000623	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PTGS2—urinary bladder cancer	6.17e-05	0.000605	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PTGS2—urinary bladder cancer	5.91e-05	0.00058	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PTEN—urinary bladder cancer	5.61e-05	0.00055	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PTEN—urinary bladder cancer	5.38e-05	0.000528	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—EP300—urinary bladder cancer	5.35e-05	0.000525	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PTGS2—urinary bladder cancer	5.2e-05	0.00051	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PTEN—urinary bladder cancer	5.16e-05	0.000506	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—EP300—urinary bladder cancer	5.13e-05	0.000503	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—EP300—urinary bladder cancer	4.92e-05	0.000482	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PTEN—urinary bladder cancer	4.53e-05	0.000445	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—EP300—urinary bladder cancer	4.32e-05	0.000424	CbGpPWpGaD
